A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer

被引：0
|
作者：
Saito, K. O. [1 ]
Nakai, Y. [1 ]
Isayama, H. [2 ]
Ishigaki, K. [1 ]
Saito, T. [1 ]
Takahara, N. [1 ]
Mizuno, S. [1 ]
Kogure, H. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan
[2] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
737P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Hakuta, Ryunosuke
    Saito, Tomotaka
    Uchino, Rie
    Kishikawa, Takahiro
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Sasaki, Takashi
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    [J]. INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 338 - 344
  • [2] A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yousuke Nakai
    Naminatsu Takahara
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Ryunosuke Hakuta
    Tomotaka Saito
    Rie Uchino
    Takahiro Kishikawa
    Tsuyoshi Hamada
    Suguru Mizuno
    Takashi Sasaki
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    [J]. Investigational New Drugs, 2019, 37 : 338 - 344
  • [3] A phase 1 trial of GSL (gemcitabine, S-1, LV) combination therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Takahara, Naminatsu
    Mizuno, Suguru
    Hamada, Tsuyoshi
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [4] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Saito, Kei
    Sasaki, Takashi
    Takahara, Naminatsu
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Mohri, Dai
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 911 - 915
  • [5] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
    Yousuke Nakai
    Hiroyuki Isayama
    Kei Saito
    Takashi Sasaki
    Naminatsu Takahara
    Tsuyoshi Hamada
    Suguru Mizuno
    Koji Miyabayashi
    Keisuke Yamamoto
    Dai Mohri
    Hirofumi Kogure
    Natsuyo Yamamoto
    Kenji Hirano
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 911 - 915
  • [6] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [7] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
  • [8] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yoshihiro Sakamoto
    Yousuke Nakai
    Kazunaga Ishigaki
    Mariko Tanaka
    Takeyuki Watadani
    Junichi Arita
    Naminatsu Takahara
    Suguru Mizuno
    Hirofumi Kogure
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kiyoshi Hasegawa
    Masashi Fukayama
    Norihiro Kokudo
    Kazuhiko Koike
    [J]. Medical Oncology, 2018, 35
  • [9] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Sakamoto, Yoshihiro
    Nakai, Yousuke
    Ishigaki, Kazunaga
    Tanaka, Mariko
    Watadani, Takeyuki
    Arita, Junichi
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Hasegawa, Kiyoshi
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    [J]. MEDICAL ONCOLOGY, 2018, 35 (07)
  • [10] Phase I study of gemcitabine and S-1 combination therapy in patients with advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    Furuse, J
    Ishii, H
    Nagase, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 353S - 353S
12345